About Us
+
Leadership
+
Initiatives
+
Awards
+
Press Releases
+
Contact Us
+
Jobs
+
Events
+
User Group
Solutions
+
i.v.STATION® ONCO
+
i.v.STATION®
+
CytoCare®
+
i.v.SOFT®
+
MEDarchiver®
+
OMM
+
TPNstation®
+
i.v.Room
Installations
testimonials
Partnerships
+
Distributors
+
Development Partners
+
i.v.Room of the Future Partners
Compare Products
+
i.v.Station vs RIVA
+
i.v.SOFT Assist vs ?
+
klas
Newsroom
Downloads
Research Links
About Us
Founded in 2006 and now reaching 80% total IV Robots market share in the world [including over 90% the Oncology Robots global market], Health Robotics is the undisputed leading supplier of life-critical intravenous medication robots, providing over 300 hospital installations in 5 continents with the only fully-integrated robotics-based technology, IV Workflow, and manual compounding software automation solution. Health Robotics’ second generation solutions [i.v.STATION, i.v.SOFT, and i.v.STATION ONCO] have been found [through scientific and peer-reviewed studies 1,2] to greatly contribute to ease hospitals’ growing pressures to improve patient safety [1], increase throughput, and contain costs [1]. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics’ medical devices and integrated workflow solutions help hospitals eliminate life-threatening drug [1] and diluent [1] exchange errors, improve drug potency [2], decrease other medical mistakes and sterility risks, work more efficiently [1], reduce waste and controlled substances’ diversion, and diminish the gap between rising patient volume/acuity and scarce nursing and pharmacy staff.
________________________
[1] Impact of Robotic Antineoplastic Preparation on Safety, Workflow, Costs. Seger, Churchill, Keohane, Belisle, Wong, Sylvester, Chesnick, Burdick, Wien, Cotugno, Bates, and Rothschild. Brigham & Women’s Hospital, Massachusetts College of Pharmacy, and Harvard Medical School. Journal of Oncology Practice, Nov. 2012, Volume 8, number 6.
[2] Validation of an automated method for compounding monoclonal antibody patient doses: case studies of Avastin®, Remicade®, and Herceptin®. Peters, Capelle, Arvinte, van de Garde. St. Antonius Hospital. mAbs January 2013, Volume 5, Issue 1.
Customer Testimonials
News
+ show all
American Pharmacy Magazine Article [Sponsored by Intelligent Hospital Systems] Compares i.v.STATION Robot to IHS’ RIVA
Local Government Announces Cost and Safety Benefits of First i.v.STATION Robot at University Hospital in African Continent
Health Robotics Appoints Gordon Meyer to Board of Directors
Health Robotics Reports 28 New Agreements in 1Q2013, including 18 Contracts in the United States of America
Health Robotics Expands IV Bag Support to Hospira’s LifeCareTM; Cuts Fresenius Support After RIVA Decision
Health Robotics’ Convention Demonstrations at Amerinet [Orlando], ASHP [Minneapolis], and Premier [San Antonio]
Health Robotics Appoints Steve Thomas to Board of Directors
Amerinet Choice Awards Health Robotics With 5-Year Sole-Source Contract for IV Robotics and IV Workflow
Health Robotics Reports 106 Total New Sales in 2012, Including 27 New Sales in 4Q, Beating FY2011 Record
Health Robotics Expands into Qatar with i.v.STATION Robot Pediatric Installation at Hamadʼs Al-Wakra Hospital
Dear user,
Javascript is deactivated on this Browser. So some functionality of this Website will not work.